Add to ORKGGermline mutations that inactivate BRCA1 are responsible for breast and ovarian cancer susceptibility. One possible outcome of genetic testing for BRCA1 is the finding of a genetic varian
Ovarian cancer is a heterogeneous disease that encompasses a number of different cellular subtypes, ...
Germ-line mutations in the BRCA1 gene cause hereditary predisposition to breast and ovarian cancer. ...
Hereditary breast and ovarian cancer is an inherited syndrome associated with BRCA1/2 germline defec...
Germline Mutations that inactivate BRCA1 are responsible for breast and ovarian cancer Susceptibilit...
Background: BRCA1 is a tumour suppressor with pleiotropic actions. Germline mutations in BRCA1 are r...
A mutation in the BRCA1 gene may confer substantial risk for breast and/or ovarian cancer. However, ...
Pathogenic germline mutations occurring in the BRCA1 (MIM:113705 ) and BRCA2 (MIM: 600185) , which a...
Germline mutations in BRCA1 gene account for varying proportions of breast/ovarian cancer families, ...
The assessment of BRCA1 and BRCA2 coding sequences to identify pathogenic mutations associated with ...
BRCA1 and BRCA2 are the genes related with breast and ovarian cancer. They have function in DNA repa...
Genetic testing allows for the identification of germline DNA variations, which are associated with ...
The aim of this study was to estimate the contribution of deleterious mutations in BRCA1, BRCA2, MLH...
The objective of this study was to provide more accurate frequency estimates of breast cancer suscep...
The assessment of BRCA1 and BRCA2 coding sequences to identify pathogenic mutations associated with ...
We analyzed 16 Italian breast and breast/ovarian cancer families for BRCA1 germline mutations using ...
Ovarian cancer is a heterogeneous disease that encompasses a number of different cellular subtypes, ...
Germ-line mutations in the BRCA1 gene cause hereditary predisposition to breast and ovarian cancer. ...
Hereditary breast and ovarian cancer is an inherited syndrome associated with BRCA1/2 germline defec...
Germline Mutations that inactivate BRCA1 are responsible for breast and ovarian cancer Susceptibilit...
Background: BRCA1 is a tumour suppressor with pleiotropic actions. Germline mutations in BRCA1 are r...
A mutation in the BRCA1 gene may confer substantial risk for breast and/or ovarian cancer. However, ...
Pathogenic germline mutations occurring in the BRCA1 (MIM:113705 ) and BRCA2 (MIM: 600185) , which a...
Germline mutations in BRCA1 gene account for varying proportions of breast/ovarian cancer families, ...
The assessment of BRCA1 and BRCA2 coding sequences to identify pathogenic mutations associated with ...
BRCA1 and BRCA2 are the genes related with breast and ovarian cancer. They have function in DNA repa...
Genetic testing allows for the identification of germline DNA variations, which are associated with ...
The aim of this study was to estimate the contribution of deleterious mutations in BRCA1, BRCA2, MLH...
The objective of this study was to provide more accurate frequency estimates of breast cancer suscep...
The assessment of BRCA1 and BRCA2 coding sequences to identify pathogenic mutations associated with ...
We analyzed 16 Italian breast and breast/ovarian cancer families for BRCA1 germline mutations using ...
Ovarian cancer is a heterogeneous disease that encompasses a number of different cellular subtypes, ...
Germ-line mutations in the BRCA1 gene cause hereditary predisposition to breast and ovarian cancer. ...
Hereditary breast and ovarian cancer is an inherited syndrome associated with BRCA1/2 germline defec...